Press Releases
Feb. 3, 2026
aTyr Pharma Announces Scheduling of FDA Type C Meeting to Discuss Efzofitimod Program in Pulmonary Sarcoidosis
Indeterminate
GlobeNewswire, Inc.
Feb. 3, 2026
Enovis to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Indeterminate
GlobeNewswire, Inc.
Feb. 3, 2026
Hagens Berman Scrutinizing Suit Against Ardent Health (ARDT) Over Alleged Revenue Cycle Deception and $97M Adjustments
Indeterminate
GlobeNewswire, Inc.
Feb. 3, 2026
Caring Brands Secures Two New U.S. Patents Strengthening Hair Enzyme Booster Technology
Indeterminate
GlobeNewswire, Inc.
Feb. 3, 2026
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire, Inc.
Feb. 3, 2026
AB Global Achieves WBENC Certification, Strengthening Its Position as a Woman-Owned Industry Leader
Neutral
EIN Presswire
Feb. 3, 2026
Louisiana Startup SleepNavigator® Secures Statewide Investment to Scale Sleep Care Technology Nationally
Neutral
EIN Presswire
Feb. 3, 2026
LeonaBio Appoints Industry Veteran Mark F. Kubik as Chief Business Officer
Indeterminate
GlobeNewswire, Inc.
Feb. 3, 2026
zSpace Career Explorer™ Powered by Career Coach AI™ Receives Tech & Learning’s Best of 2025 Award of Excellence
Indeterminate
GlobeNewswire, Inc.
Feb. 3, 2026
Isaac Health Named to the 2026 New York Digital Health 100
Neutral
EIN Presswire
Feb. 3, 2026
X4 Pharmaceuticals to Participate in Guggenheim’s Emerging Outlook: Biotech Summit 2026
Indeterminate
GlobeNewswire, Inc.
Feb. 3, 2026
HyOrc Corporation Announces Uplist to OTCQB Venture Market
Indeterminate
GlobeNewswire, Inc.
Feb. 3, 2026
OrthoPediatrics Announces Expanded Enabling Technology Market Opportunity
Indeterminate
GlobeNewswire, Inc.
Feb. 3, 2026
NMD Pharma announces topline results from its Phase 2a study of ignaseclant in Charcot-Marie-Tooth disease Types 1 and 2
Indeterminate
GlobeNewswire, Inc.
Feb. 3, 2026
Peer-reviewed publication validates Cylinder Health savings
Indeterminate
GlobeNewswire, Inc.